Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Celcuity Inc. - Common Stock (NQ:CELC)

75.37 -1.79 (-2.32%)
Streaming Delayed Price Updated: 11:42 AM EST, Nov 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Celcuity Inc. - Common Stock

< Previous 1 2 3 4 Next >
These stocks are moving in today's session
Let's have a look at what is happening on the US markets one hour before the close of the markets on Monday. Below you can find the top gainers and losers in today's session. 
Via Chartmill
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Top movers analysis in the middle of the day on 2025-10-20: top gainers and losers in today's session.
Curious to know what's happening on the US markets in the middle of the day on Monday? Join us as we explore the top gainers and losers in today's session. 
Via Chartmill
Earnings Scheduled For August 14, 2025
 
Via Benzinga
Insights into Celcuity's Upcoming Earnings
 
Via Benzinga
A Peek at Celcuity's Future Earnings
 
Via Benzinga
Gapping stocks in Monday's session
Today's session on Monday is marked by notable gaps in various stocks. Stay informed with the gap up and gap down stocks in today's session. 
Via Chartmill
WW International, Replimune Group, Datavault AI, GRAIL And Other Big Stocks Moving Higher On Monday
 
Via Benzinga
Topics Artificial Intelligence
Top 1% Celcuity Shoots To Record High On Roche-Rivaling Breast Cancer Results
The company said its breast cancer treatment delayed progression for a median of 19.7 months in some patients. 
Via Investor's Business Daily
Topics Government
Dow Jumps Over 200 Points; Cleveland-Cliffs Shares Jump After Q3 Results
 
Via Benzinga
Topics Stocks
These stocks are moving in today's pre-market session
As we await the opening of the US market on Monday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment. 
Via Chartmill
12 Health Care Stocks Moving In Monday's Pre-Market Session
 
Via Benzinga
Why Delcath Systems Shares Are Trading Higher By Over 14%; Here Are 20 Stocks Moving Premarket
 
Via Benzinga
Celcuity Q2 Results Highlight Cash Surge
Via The Motley Fool
Celcuity (CELC) Q2 2025 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Celcuity Expenses Jump 81 Percent
Via The Motley Fool
CELCUITY INC (NASDAQ:CELC) Reports Q2 2025 Earnings Miss Amid Clinical Progress in Gedatolisib Trials
Celcuity (CELC) reported Q2 2025 results with a wider-than-expected EPS loss but revenue in line. Clinical progress in breast cancer trials drives investor optimism despite financial misses. 
Via Chartmill
Topics Earnings
Unusual volume stocks are being observed in Wednesday's session.
The trading volume of these stocks is deviating from the norm in today's session. 
Via Chartmill
The trading volume of these stocks is deviating from the norm in today's session.
Discover the stocks with unexpected trading volume in today's session on the US markets. 
Via Chartmill
12 Health Care Stocks Moving In Monday's Intraday Session
 
Via Benzinga
Crude Oil Gains 2%; CEA Industries Shares Spike Higher
 
Via Benzinga
Alerus Financial Posts Better-Than-Expected Earnings, Joins Celcuity, SES AI, Abercrombie & Fitch And Other Big Stocks Moving Higher On Monday
 
Via Benzinga
Topics Artificial Intelligence
US Stocks Mixed; Enterprise Products Partners Posts Upbeat Earnings
 
Via Benzinga
This Pharma Stock Rose 200% On Monday Morning And Retail Says Valuation Could Rise To $5B: Here’s Why
Sara Hurvitz, co-principal investigator for the trial, said that the data for both combination treatments in the trials are “potentially practice-changing.” 
Via Stocktwits
Topics Death
Celcuity Stock Skyrockets On Breakthrough Trial Data For Heavily Pretreated Breast Cancer
Celcuity shares jump as gedatolisib shows strong efficacy in HR+/HER2- breast cancer Phase 3 trial, with FDA filing expected in late 2025. 
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
 
Via Benzinga
Why Celcuity Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket
 
Via Benzinga
Top movers in Friday's after hours session
Discover the top movers in Friday's after-hours session and stay informed about the post-market dynamics. 
Via Chartmill
Northrop Grumman Posts Downbeat Results, Joins Halliburton And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
 
Via Benzinga
Earnings Scheduled For May 14, 2025
 
Via Benzinga
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.